Literature DB >> 9850411

Serological similarities between hyperreactive malarial splenomegaly and splenic lymphoma in west Africa.

S Wallace1, G Bedu-Addo, T R Rutherford, I Bates.   

Abstract

In West Africa hyperreactive malarial splenomegaly (HMS) and splenic lymphoma with villous lymphocytes (SLVL) are demographically and clinically indistinguishable. Determination of lymphocyte clonality is needed to differentiate clearly between these 2 disorders. To obtain evidence to support our hypothesis that HMS and SLVL are aetiologically related we studied the serological profile of malaria-related antibodies in HMS and SLVL in West Africa. We found that in SLVL total immunoglobulin M and antimalarial antibody levels were markedly raised, a combination which is characteristic of HMS. These findings strongly support a developmental relationship between HMS and SLVL in tropical Africa and implicate malaria in this process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850411     DOI: 10.1016/s0035-9203(98)91095-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

Review 1.  The hyper-reactive malarial splenomegaly: a systematic review of the literature.

Authors:  Stefania Leoni; Dora Buonfrate; Andrea Angheben; Federico Gobbi; Zeno Bisoffi
Journal:  Malar J       Date:  2015-04-29       Impact factor: 2.979

2.  Absence of erythrocyte sequestration and lack of multicopy gene family expression in Plasmodium falciparum from a splenectomized malaria patient.

Authors:  Anna Bachmann; Claudia Esser; Michaela Petter; Sabine Predehl; Vera von Kalckreuth; Stefan Schmiedel; Iris Bruchhaus; Egbert Tannich
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

3.  Immunological characteristics of hyperreactive malarial splenomegaly syndrome in sudanese patients.

Authors:  Tayseer Alkadarou; Ahmed Musa; Abedelgader Alkadarou; Mohamed S Mahfouz; Marita Troye-Blomberg; Ahmed M Elhassan; Ibrahim M Elhassan
Journal:  J Trop Med       Date:  2013-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.